Issue 1, 2021
From the journal:

Dalton Transactions

A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells†

Angelica E. Graminha, ORCID logo *ab   João Honorato, ORCID logo a   Rodrigo S. Correa,c   Marcia R. Cominetti, ORCID logo b   Antônio C. S. Menezesd  and  Alzir A. Batista ORCID logo a  

* Corresponding authors

a Departamento de Química, Universidade Federal de São Carlos – UFSCar, Rodovia Washington Luís Km 235, CP 676, 13561-901, São Carlos, SP, Brazil
E-mail: aegraminha@gmail.com

b Departamento de Gerontologia, Universidade Federal de São Carlos – UFSCar, Rodovia Washington Luís Km 235, CP 676, 13561-901, São Carlos, SP, Brazil

c Departamento de Química, Universidade Federal de Ouro Preto (UFOP), CP: 35.400-000, Ouro Preto MG, Brazil

d Centro de Ciências Exatas e de Tecnologia, Universidade Estadual de Goiás – UEG, BR 153, CP 459, 75132-903, Anápolis, GO, Brazil

Abstract

This work describes the synthesis of three new ruthenium(II) complexes with gallic acid and derivatives of the general formula [Ru(L)(dppb)(bipy)]PF6, where L = gallate (GAC), benzoate (BAC), and esterified-gallate (EGA), bipy = 2,2′-bipyridine and dppb = 1,4-bis(diphenylphosphino)butane. The complexes were characterized by elemental analysis, molar conductivity, NMR, cyclic voltammetry, UV-vis and IR spectroscopy, and two of them by X-ray crystallography. Cell viability assays show promising results, indicating higher cytotoxicity of the complexes in MDA-MB-231 cells, a triple-negative breast cancer (TNBC) cell line, compared with the hormone-dependent MCF-7 cell line. Studies in vitro with the MDA-MB-231 cell line showed that only Ru(BAC) and Ru(GAC) interacted with BSA. Besides that, the Ru(GAC) complex, which has a polyphenolic acid, interacted in an apo-Tf structure and function dependent manner and it was able to inhibit the formation of reactive oxygen species. Ru(GAC) was able to cause damage to the cellular cytoskeleton leading to inhibition of some cellular processes of TNBC cells, such as invasion, migration, and adhesion.

Graphical abstract: A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/D0DT03490H
Article type
Paper
Submitted
08 Oct 2020
Accepted
24 Nov 2020
First published
24 Nov 2020

Dalton Trans., 2021,50, 323-335

Permissions

Request permissions

A novel ruthenium(II) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells

A. E. Graminha, J. Honorato, R. S. Correa, M. R. Cominetti, A. C. S. Menezes and A. A. Batista, Dalton Trans., 2021, 50, 323 DOI: 10.1039/D0DT03490H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements